Abstract
Enterotoxigenic Escherichia coli (ETEC) is the most common agent of diarrhea morbidity in developing countries. ETEC adheres to host intestinal epithelial cells via various colonization factors. The CooD and CotD proteins play a significant role in bacteria binding to the intestinal epithelial cells as adhesin tip subunits of CS1 and CS2 pili. The purpose here was to design a new construction containing cooD and cotD genes and use several types of bioinformatics software to predict the structural and immunological properties of the designed antigen. The fusion gene was synthesized with codon bias of E. coli in order to increase the expression level of the protein. The amino acid sequences, protein structure, and immunogenicity properties of potential antigens were analyzed in silico. The chimeric protein was expressed in E. coliBL21 (DE3). The antigenicity of the recombinant proteins was verified by Western blotting and ELISA. In order to assess the induced immunity, the immunized mice were challenged with wild-type ETEC by an intraperitoneal route. Immunological analyses showed the production of a high titer of IgG serum with no sign of serum-mucosal IgA antibody response. The result of the challenge assay showed that 30% of immunized mice survived. The results of this study showed that CooD-CotD recombinant protein can stimulate immunity against ETEC. The designed chimera could be a prototype for the subunit vaccine, which is worthy of further consideration.
Journal Section:
Research Article
References
1.
Ahmed
T
, Bhuiyan
TR
, Zaman
K
, Sinclair
D
, Qadri
F
. Vaccines for preventing enterotoxigenic Escherichia coli (ETEC) diarrhoea. Cochrane Database of Systematic Reviews. 2013
(7).2.
Alerasol
M
, Mousavi Gargari
SL
, Nazarian
S
, Bagheri
S
. Immunogenicity of a fusion protein comprising coli surface antigen 3 and labile B subunit of enterotoxigenic Escherichia coli
. Iran Biomed J
. 2014
;18
(4
):212
–8
.
[PubMed]
2008-823X3.
Amani
J
, Salmanian
AH
, Rafati
S
, Mousavi
SL
. Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7
. Vaccine
. 2010
Oct
;28
(42
):6923
–9
.
[PubMed]
0264-410X4.
Baxter
D
. Active and passive immunity, vaccine types, excipients and licensing
. Occup Med (Lond)
. 2007
Dec
;57
(8
):552
–6
.
[PubMed]
0962-74805.
Berzofsky
JA
, Ahlers
JD
, Belyakov
IM
. Strategies for designing and optimizing new generation vaccines
. Nat Rev Immunol
. 2001
Dec
;1
(3
):209
–19
.
[PubMed]
1474-17336.
Bornhorst
JA
, Falke
JJ
. Purification of proteins using polyhistidine affinity tags
. Methods Enzymol
. 2000
;326
:245
–54
.
[PubMed]
0076-68797.
Byrd
W
, Cassels
FJ
. Mucosal immunization of BALB/c mice using enterotoxigenic Escherichia coli colonization factors CFA/I and CS6 administered with and without a mutant heat-labile enterotoxin
. Vaccine
. 2003
May
;21
(17-18
):1884
–93
.
[PubMed]
0264-410X8.
Chakraborty
S
, Randall
A
, Vickers
TJ
, Molina
D
, Harro
CD
, DeNearing
B
, et al.. Interrogation of a live-attenuated enterotoxigenic Escherichia coli vaccine highlights features unique to wild-type infection. npj
. Vaccines (Basel)
. 2019
;4
(1
):1
–9
.2076-393X9.
Cravioto
A
, Gross
R
, Scotland
S
, Rowe
B
. Mannose-resistant haemagglutination of human erythrocytes by strains of Escherichia coli from extraintestinal sources: lack of correlation with colonisation factor antigen (CFA/I)
. FEMS Microbiol Lett
. 1979
;6
(1
):41
–4
. 0378-109710.
Crowe
J
, Dobeli
H
, Gentz
R
, Hochuli
E
, Stiiber
D
, Henco
K.
6xffis-ni-nta chromatography as a superior technique in recombinant protein expression/purification. Protocols for gene analysis. 1994
:371-87.11.
de Smit
MH
, van Duin
J
. Control of translation by mRNA secondary structure in Escherichia coli. A quantitative analysis of literature data
. J Mol Biol
. 1994
Nov
;244
(2
):144
–50
.
[PubMed]
0022-283612.
Fleckenstein
JM
, Hardwidge
PR
, Munson
GP
, Rasko
DA
, Sommerfelt
H
, Steinsland
H
. Molecular mechanisms of enterotoxigenic Escherichia coli infection
. Microbes Infect
. 2010
Feb
;12
(2
):89
–98
.
[PubMed]
1286-457913.
Froehlich
BJ
, Karakashian
A
, Melsen
LR
, Wakefield
JC
, Scott
JR
. CooC and CooD are required for assembly of CS1 pili
. Mol Microbiol
. 1994
May
;12
(3
):387
–401
.
[PubMed]
0950-382X14.
Galkin
VE
, Kolappan
S
, Ng
D
, Zong
Z
, Li
J
, Yu
X
, et al.. The structure of the CS1 pilus of enterotoxigenic Escherichia coli reveals structural polymorphism
. J Bacteriol
. 2013
Apr
;195
(7
):1360
–70
.
[PubMed]
0021-919315.
Gasteiger
E
, Hoogland
C
, Gattiker
A
, Wilkins
MR
, Appel
RD
, Bairoch
A
. Protein identification and analysis tools on the ExPASy server. The proteomics protocols handbook
. Springer
; 2005
. pp. 571
–607
. 16.
Jansson
L
, Tobias
J
, Jarefjäll
C
, Lebens
M
, Svennerholm
AM
, Teneberg
S
. Sulfatide recognition by colonization factor antigen CS6 from enterotoxigenic Escherichia coli
. PLoS One
. 2009
;4
(2
):e4487
.
[PubMed]
1932-620317.
Johnson
TJ
, Nolan
LK
. Pathogenomics of the Virulence Plasmids of Escherichia coli. Microbiology and molecular biology reviews
. Microbiol Mol Biol Rev
. 2010
;74
(3
):477
–8
. 1092-217218.
Jordi
BJ
, van Vliet
AH
, Willshaw
GA
, van der Zeijst
BA
, Gaastra
W
. Analysis of the first two genes of the CS1 fimbrial operon in human enterotoxigenic Escherichia coli of serotype 0139:H28
. FEMS Microbiol Lett
. 1991
May
;64
(2-3
):265
–70
.
[PubMed]
0378-109719.
Kazemi
R
, Amani
J
, Akhavian
A
, Mousavi
A
, Salmanian
AH
. Design and analysis of trivalent chimeric vaccine candidate against three enterotoxigenic bacteria: an in-silico approach
. Minerva Biotecnol
. 2017
;29
(2
):62
–75
.1120-482620.
Khoobbakht
D
, Amani
J
, Zare
S
, Nourmohammadi
Z
. Cloning and evaluation of gene expression and purification of gene encoding recombinant protein containing binding subunit of coli surface antigens CS1 and CS2 from Enterotoxigenic Escherichia coli
. Journal of Fasa University of Medical Sciences
. 2019
;8
(4
):1025
–35
.21.
Liaqat
I
, Sakellaris
H
. Biofilm formation and binding specificities of CFA/I, CFA/II and CS2 adhesions of enterotoxigenic Escherichia coli and Cfae-R181A mutant
. Braz J Microbiol
. 2012
Jul
;43
(3
):969
–80
.
[PubMed]
1517-838222.
Lundgren
A
, Jertborn
M
, Svennerholm
AM
. Induction of long term mucosal immunological memory in humans by an oral inactivated multivalent enterotoxigenic Escherichia coli vaccine
. Vaccine
. 2016
Jun
;34
(27
):3132
–40
.
[PubMed]
0264-410X23.
McArthur
MA
, Chen
WH
, Magder
L
, Levine
MM
, Sztein
MB
. Impact of CD4+ T cell responses on clinical outcome following oral administration of wild-type enterotoxigenic Escherichia coli in humans
. PLoS Negl Trop Dis
. 2017
Jan
;11
(1
):e0005291
.
[PubMed]
1935-272724.
Meckelein
B
, Externest
D
, Schmidt
MA
, Frey
A
. Contribution of serum immunoglobulin transudate to the antibody immune status of murine intestinal secretions: influence of different sampling procedures
. Clin Diagn Lab Immunol
. 2003
Sep
;10
(5
):831
–4
.
[PubMed]
1071-412X25.
Nandre
RM
, Ruan
X
, Duan
Q
, Sack
DA
, Zhang
W
. Antibodies derived from an enterotoxigenic Escherichia coli (ETEC) adhesin tip MEFA (multiepitope fusion antigen) against adherence of nine ETEC adhesins: CFA/I, CS1, CS2, CS3, CS4, CS5, CS6, CS21 and EtpA
. Vaccine
. 2016
Jun
;34
(31
):3620
–5
.
[PubMed]
0264-410X26.
Nazarian
S
, Amani
J
. Pathogenesis and Vaccines against Enterotoxigenic Escherichia Coli
. Babol-Jbums
. 2017
;19
(6
):13
–21
.27.
Nazarian
S
, Gargari
SL
, Rasooli
I
, Hasannia
S
, Pirooznia
N
. A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli
. Microbiol Res
. 2014
Feb-Mar
;169
(2-3
):205
–12
.
[PubMed]
0944-501328.
Perez-Casal
J
, Swartley
JS
, Scott
JR
. Gene encoding the major subunit of CS1 pili of human enterotoxigenic Escherichia coli
. Infect Immun
. 1990
Nov
;58
(11
):3594
–600
.
[PubMed]
0019-956729.
Qadri
F
, Svennerholm
AM
, Faruque
AS
, Sack
RB
. Enterotoxigenic Escherichia coli in developing countries: epidemiology, microbiology, clinical features, treatment, and prevention
. Clin Microbiol Rev
. 2005
Jul
;18
(3
):465
–83
.
[PubMed]
0893-851230.
Ramer
SW
, Schoolnik
GK
, Wu
CY
, Hwang
J
, Schmidt
SA
, Bieber
D
. The type IV pilus assembly complex: biogenic interactions among the bundle-forming pilus proteins of enteropathogenic Escherichia coli
. J Bacteriol
. 2002
Jul
;184
(13
):3457
–65
.
[PubMed]
0021-919331.
Rosano
GL
, Ceccarelli
EA
. Recombinant protein expression in Escherichia coli: advances and challenges
. Front Microbiol
. 2014
Apr
;5
:172
.
[PubMed]
1664-302X32.
Sakellaris
H
, Munson
GP
, Scott
JR
. A conserved residue in the tip proteins of CS1 and CFA/I pili of enterotoxigenic Escherichia coli that is essential for adherence
. Proc Natl Acad Sci USA
. 1999
a Oct
;96
(22
):12828
–32
.
[PubMed]
0027-842433.
Sakellaris
H
, Penumalli
VR
, Scott
JR
. The level of expression of the minor pilin subunit, CooD, determines the number of CS1 pili assembled on the cell surface of Escherichia coli
. J Bacteriol
. 1999
b Mar
;181
(5
):1694
–7
.
[PubMed]
0021-919334.
Schmitt
J
, Hess
H
, Stunnenberg
HG
. Affinity purification of histidine-tagged proteins
. Mol Biol Rep
. 1993
Oct
;18
(3
):223
–30
.
[PubMed]
0301-485135.
Sen
TZ
, Jernigan
RL
, Garnier
J
, Kloczkowski
A
. GOR V server for protein secondary structure prediction
. Bioinformatics
. 2005
Jun
;21
(11
):2787
–8
.
[PubMed]
1367-480336.
Seo
H
, Nandre
RM
, Nietfeld
J
, Chen
Z
, Duan
Q
, Zhang
W
. Antibodies induced by enterotoxigenic Escherichia coli (ETEC) adhesin major structural subunit and minor tip adhesin subunit equivalently inhibit bacteria adherence in vitro
. PLoS One
. 2019
May
;14
(5
):e0216076
.
[PubMed]
1932-620337.
Solanki
V
, Tiwari
M
, Tiwari
V
. Prioritization of potential vaccine targets using comparative proteomics and designing of the chimeric multi-epitope vaccine against Pseudomonas aeruginosa
[Nature Publisher Group]
. Sci Rep
. 2019
Mar
;9
(1
):5240
.
[PubMed]
2045-232238.
Spiekermann
GM
, Finn
PW
, Ward
ES
, Dumont
J
, Dickinson
BL
, Blumberg
RS
, et al.. Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung
. J Exp Med
. 2002
Aug
;196
(3
):303
–10
.
[PubMed]
0022-100739.
Svennerholm
AM
. From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
. Indian J Med Res
. 2011
Feb
;133
(2
):188
–96
.
[PubMed]
0971-591640.
Svennerholm
AM
, Lundgren
A
. Recent progress toward an enterotoxigenic Escherichia coli vaccine
. Expert Rev Vaccines
. 2012
Apr
;11
(4
):495
–507
.
[PubMed]
1476-058441.
Svennerholm
AM
, Tobias
J
. Vaccines against enterotoxigenic Escherichia coli
. Expert Rev Vaccines
. 2008
Aug
;7
(6
):795
–804
.
[PubMed]
1476-058442.
Tobias
J
, Svennerholm
AM
, Holmgren
J
, Lebens
M
. Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines
. Appl Microbiol Biotechnol
. 2010
Jul
;87
(4
):1355
–65
.
[PubMed]
0175-759843.
Voegele
K
, Sakellaris
H
, Scott
JR
. CooB plays a chaperone-like role for the proteins involved in formation of CS1 pili of enterotoxigenic Escherichia coli
. Proc Natl Acad Sci USA
. 1997
Nov
;94
(24
):13257
–61
.
[PubMed]
0027-842444.
von Mentzer
A
, Tobias
J
, Wiklund
G
, Nordqvist
S
, Aslett
M
, Dougan
G
, et al.. Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC)
. Sci Rep
. 2017
Oct
;7
(1
):12514
.
[PubMed]
2045-232245.
Young
CL
, Britton
ZT
, Robinson
AS
. Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications
. Biotechnol J
. 2012
May
;7
(5
):620
–34
.
[PubMed]
1860-676846.
Yu
J
, Cassels
F
, Scharton-Kersten
T
, Hammond
SA
, Hartman
A
, Angov
E
, et al.. Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli
. Infect Immun
. 2002
Mar
;70
(3
):1056
–68
.
[PubMed]
0019-956747.
Zeinalzadeh
N
, Salmanian
AH
, Goujani
G
, Amani
J
, Ahangari
G
, Akhavian
A
, et al.. A Chimeric protein of CFA/I, CS6 subunits and LTB/STa toxoid protects immunized mice against enterotoxigenic Escherichia coli
. Microbiol Immunol
. 2017
Jul
;61
(7
):272
–9
.
[PubMed]
0385-560048.
Zhang
W
, Sack
DA
. Current progress in developing subunit vaccines against enterotoxigenic Escherichia coli-associated diarrhea
. Clin Vaccine Immunol
. 2015
Sep
;22
(9
):983
–91
.
[PubMed]
1556-681149.
Zuker
M
. Mfold web server for nucleic acid folding and hybridization prediction
. Nucleic Acids Res
. 2003
Jul
;31
(13
):3406
–15
.
[PubMed]
0305-1048© 2020 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2020
You do not currently have access to this content.
